    {
        "resultNumber": "1",
        "trialId": "NCT03377387",
        "trialTitle": "Neratinib and Xeloda for Metastatic HER2+ Breast Cancer",
        "scientificTitle": "Phase Ib/II Study of Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer (NCT03377387)",
        "phaseNumber": "I-II",
        "purpose": "To study the safety and effects (good and bad) of using a targeted therapy in combination with different doses of a standard chemotherapy.",
        "whoIsThisFor": "Women with HER2 positive metastatic (stage IV) breast cancer who have received prior Herceptin. You may have had up to 4 prior regimens of chemotherapy",
        "whatIsInvolved": "<p class=\"seamTextPara\">\nYou will receive the following: \n</p>\n\n<ul class=\"seamTextUnorderedList\">\n<li class=\"seamTextUnorderedListItem\">Capacitabine (Xeloda速), by mouth, daily (1 week on, 1 week off) </li>\n<li class=\"seamTextUnorderedListItem\">Neratinib (Nerlynx速), by mouth daily</li></ul>\n",
        "whatIsBeingStudied": "<p class=\"seamTextPara\">\nThe targeted therapy that is being used in this study is neratinib (Nerlynx速). It is approved to treat certain patients with HER2+ early-stage breast cancer. \n</p>\n\n<ul class=\"seamTextUnorderedList\">\n<li class=\"seamTextUnorderedListItem\">Capacitabine (Xeloda速) is approved by the FDA for treating advanced breast cancer.</li>\n</ul>\n",
        "learnMore": "",
        "ctGovLink": "https://clinicaltrials.gov/ct2/show/NCT03377387",
        "eligibilityCriteriaLink": "https://clinicaltrials.gov/ct2/show/NCT03377387#eligibility",
        "trialCategories": [
            "METASTATIC",
            "ANTI_HER2_THERAPY",
            "TREATMENT_CHEMOTHERAPY",
            "TREATMENT_BIOLOGICAL"
        ],
        "trialMutations": [],
        "newTrialFlag": false,
        "zip": "18103",
        "distance": "2843",
        "siteName": "Lehigh Valley Health Network",
        "city": "Allentown",
        "state": "PA",
        "visits": "Monthly visits, ongoing",
        "latitude": 40.595097,
        "longitude": -75.459156,
        "contactName": "Ranju Gupta, MD ",
        "contactPhone": "610-402-7880",
        "contactEmail": null,
        "noVisitsRequiredFlag": false,
        "numberOfSites": "10"
    }
